BioTissue introduces procedure to treat conjunctivochalasis, restore tear reservoir

BioTissue Inc. is introducing an amniotic membrane-based treatment for conjunctivochalasis dry eye at the American Society of Cataract and Refractive Surgery meeting in Boston, the company announced in a news release. The Reservoir Restoration procedure uses cryopreserved amniotic membrane to restore the tear reservoir and tear meniscus, and inhibits metalloproteinase activity. The procedure involves the company’s proprietary AmnioGraft replacement tissue product.